Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up.

M Wirth; C Tyrrell; K Delaere; M Sánchez-Chapado; J Ramon; D M A Wallace; J Hetherington; F Pina; C F Heyns; S Navani

doi:10.1038/sj.pcan.4500916

Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up.

NobleID: NI6P51W76R46S40
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/D04CF1F7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D04CF1F7.svg?ark=w1%2F20260515%2FD04CF1F7&value=id)](https://nobleid.org/work/w1/20260515/D04CF1F7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up.

NobleID: NI6P51W76R46S40
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/D04CF1F7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D04CF1F7.svg?ark=w1%2F20260515%2FD04CF1F7&value=id)](https://nobleid.org/work/w1/20260515/D04CF1F7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work